FIELD: medicine. SUBSTANCE: method involves applying beta-application therapy. Total focal dose is equal to 100 Gr on the tumor base and conjunctiva of both eyes vaults during 5 fractions. EFFECT: full tumor regression achieved; no injuries in surrounding tissues. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING UVEAL MELANOMA | 2000 |
|
RU2169006C1 |
METHOD FOR TREATING LARGE MUTIPLE CENTER RETINOBASLOMES | 2001 |
|
RU2192862C1 |
METHOD FOR PREVENTING RADIAL PALPEBRAL LESIONS AT PROTONOTHERAPY OF MALIGNANT ORBITAL TUMORS | 2005 |
|
RU2284802C1 |
METHOD OF TREATING VISUAL ORGAN LYMPHOMAS | 2013 |
|
RU2514638C1 |
METHOD FOR PLASTY OF CAVITY AT ANOPHTHALMIA COMPLICATED WITH POSTRADIATION ATROPHY OF ORBITAL TISSUES | 2000 |
|
RU2192211C2 |
METHOD OF TREATING MALIGNANT TUMOR OF EYELID SKIN AND CONJUNCTIVA | 0 |
|
SU1556673A1 |
UVEAL MELANOMA BRACHYTHERAPY APPROACH | 2007 |
|
RU2358662C1 |
SURGICAL METHOD FOR TREATING THE PATIENTS SUFFERING FROM ENDOCRINE OPHTHALMOPATHY IN DECOMPENSATION PERIOD AND ENDOCRINE MYOPATHY | 2001 |
|
RU2192823C1 |
METHOD FOR TREATING THE CASES OF ANOPHTHALM AGGRAVATED BY POSTRADIATION ORBIT ATROPHY BY APPLYING DEFERRED REST STUMP FORMATION | 2000 |
|
RU2180819C2 |
METHOD OF CHOROID MELANOME TREATMENT | 2006 |
|
RU2359648C2 |
Authors
Dates
2001-03-20—Published
2000-05-15—Filed